Published in Am J Pathol on November 01, 2003
Nipah virus in Lyle's flying foxes, Cambodia. Emerg Infect Dis (2005) 3.77
Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A (2005) 3.18
Nipah virus: vaccination and passive protection studies in a hamster model. J Virol (2004) 2.09
A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection. PLoS Pathog (2009) 2.09
Feline model of acute nipah virus infection and protection with a soluble glycoprotein-based subunit vaccine. J Virol (2006) 1.87
Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog (2012) 1.68
Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLoS One (2010) 1.54
Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol (2011) 1.40
Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). J Immunol Methods (2011) 1.31
Poly(I)-poly(C12U) but not ribavirin prevents death in a hamster model of Nipah virus infection. Antimicrob Agents Chemother (2006) 1.27
Recombinant nipah virus vaccines protect pigs against challenge. J Virol (2006) 1.25
Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry. PLoS Pathog (2010) 1.25
Establishment of a Nipah virus rescue system. Proc Natl Acad Sci U S A (2006) 1.20
Interferon alfacon-1 protects hamsters from lethal pichinde virus infection. Antimicrob Agents Chemother (2005) 1.20
Endocytosis of the Nipah virus glycoproteins. J Virol (2005) 1.12
Differentiated cultures of primary hamster tracheal airway epithelial cells. In Vitro Cell Dev Biol Anim (2005) 1.08
Evidence for henipavirus spillover into human populations in Africa. Nat Commun (2014) 1.08
Nipah virus transmission in a hamster model. PLoS Negl Trop Dis (2011) 1.05
Nipah virus uses leukocytes for efficient dissemination within a host. J Virol (2011) 1.05
A new model for Hendra virus encephalitis in the mouse. PLoS One (2012) 1.04
Experimental infection of squirrel monkeys with nipah virus. Emerg Infect Dis (2010) 1.02
Henipavirus outbreaks to antivirals: the current status of potential therapeutics. Curr Opin Virol (2012) 0.98
Foodborne transmission of nipah virus in Syrian hamsters. PLoS Pathog (2014) 0.98
Duplex real-time reverse transcriptase PCR to determine cytokine mRNA expression in a hamster model of New World cutaneous leishmaniasis. BMC Immunol (2010) 0.98
Comparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamster. PLoS Negl Trop Dis (2013) 0.97
Vaccine potential of Nipah virus-like particles. PLoS One (2011) 0.97
A single amino acid substitution in the V protein of Nipah virus alters its ability to block interferon signalling in cells from different species. J Gen Virol (2006) 0.96
Lethal Nipah virus infection induces rapid overexpression of CXCL10. PLoS One (2012) 0.95
Pathology of acute henipavirus infection in humans and animals. Patholog Res Int (2011) 0.95
Targeted strategies for henipavirus therapeutics. Open Virol J (2007) 0.93
The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals. PLoS One (2010) 0.92
Viral regulatory region effects on vertical transmission of polyomavirus SV40 in hamsters. Virology (2009) 0.91
Henipavirus receptor usage and tropism. Curr Top Microbiol Immunol (2012) 0.91
Nipah virus entry and egress from polarized epithelial cells. J Virol (2013) 0.89
Selective receptor expression restricts Nipah virus infection of endothelial cells. Virol J (2008) 0.89
Nonstructural Nipah virus C protein regulates both the early host proinflammatory response and viral virulence. J Virol (2012) 0.88
Recombinant measles virus vaccine expressing the Nipah virus glycoprotein protects against lethal Nipah virus challenge. PLoS One (2013) 0.86
Hendra and nipah infection: pathology, models and potential therapies. Infect Disord Drug Targets (2011) 0.84
Viral microRNA effects on pathogenesis of polyomavirus SV40 infections in syrian golden hamsters. PLoS Pathog (2014) 0.83
Ephrin-B2 expression critically influences Nipah virus infection independent of its cytoplasmic tail. Virol J (2008) 0.83
A human lung xenograft mouse model of Nipah virus infection. PLoS Pathog (2014) 0.83
Immunization strategies against henipaviruses. Curr Top Microbiol Immunol (2012) 0.83
Molecular diagnostic and genetic characterization of highly pathogenic viruses: application during Crimean-Congo haemorrhagic fever virus outbreaks in Eastern Europe and the Middle East. Clin Microbiol Infect (2012) 0.82
Subclinical infection without encephalitis in mice following intranasal exposure to Nipah virus-Malaysia and Nipah virus-Bangladesh. Virol J (2014) 0.81
Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters. Antiviral Res (2013) 0.80
Tioman virus, a paramyxovirus of bat origin, causes mild disease in pigs and has a predilection for lymphoid tissues. J Virol (2007) 0.80
Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy. Sci Rep (2016) 0.79
Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets. J Virol (2016) 0.78
Henipavirus infections: lessons from animal models. Pathogens (2013) 0.78
The immune response to Nipah virus infection. Arch Virol (2012) 0.78
The immunomodulating V and W proteins of Nipah virus determine disease course. Nat Commun (2015) 0.78
Transcriptional profiling of the spleen in progressive visceral leishmaniasis reveals mixed expression of type 1 and type 2 cytokine-responsive genes. BMC Immunol (2014) 0.77
Animal models of disease shed light on Nipah virus pathogenesis and transmission. J Pathol (2015) 0.76
Heparan sulfate-dependent enhancement of henipavirus infection. MBio (2015) 0.76
Nipah virus infection: current scenario. Indian J Virol (2013) 0.76
Characterisation of monoclonal antibodies specific for hamster leukocyte differentiation molecules. Vet Immunol Immunopathol (2016) 0.75
Hendra virus and Nipah virus animal vaccines. Vaccine (2016) 0.75
Loss in lung volume and changes in the immune response demonstrate disease progression in African green monkeys infected by small-particle aerosol and intratracheal exposure to Nipah virus. PLoS Negl Trop Dis (2017) 0.75
Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters. PLoS Negl Trop Dis (2016) 0.75
Peri-exposure protection against Nipah virus disease using a single-dose recombinant vesicular stomatitis virus-based vaccine. NPJ Vaccines (2016) 0.75
Immunological Control of Viral Infections in Bats and the Emergence of Viruses Highly Pathogenic to Humans. Front Immunol (2017) 0.75
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect (2002) 6.40
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia. Lancet (1999) 5.14
Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med (2000) 3.12
Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. J Infect Dis (2000) 2.57
Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol (2002) 2.36
The presence of Nipah virus in respiratory secretions and urine of patients during an outbreak of Nipah virus encephalitis in Malaysia. J Infect (2001) 2.30
Comparative pathology of the diseases caused by Hendra and Nipah viruses. Microbes Infect (2001) 2.21
Treatment of acute Nipah encephalitis with ribavirin. Ann Neurol (2001) 1.87
Relapsed and late-onset Nipah encephalitis. Ann Neurol (2002) 1.69
Elucidation of Nipah virus morphogenesis and replication using ultrastructural and molecular approaches. Virus Res (2003) 1.43
Risk factors for Nipah virus infection among abattoir workers in Singapore. J Infect Dis (2000) 1.23
Introduction to Current focus on Hendra and Nipah viruses. Microbes Infect (2001) 1.20
A guinea-pig model of Hendra virus encephalitis. J Comp Pathol (2001) 1.07
Risk factors for Nipah virus transmission, Port Dickson, Negeri Sembilan, Malaysia: results from a hospital-based case-control study. Southeast Asian J Trop Med Public Health (2000) 1.00
Detection of dengue virus by in situ hybridization. J Virol Methods (1993) 0.97
Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999. Emerg Infect Dis (2001) 0.92
Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect (2002) 6.40
Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol (2002) 4.63
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis (2004) 3.81
Complete genome sequences and phylogenetic analysis of West Nile virus strains isolated from the United States, Europe, and the Middle East. Virology (2002) 3.79
Nipah virus in Lyle's flying foxes, Cambodia. Emerg Infect Dis (2005) 3.77
A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A (2002) 2.65
Introduction of West Nile virus in the Middle East by migrating white storks. Emerg Infect Dis (2002) 2.63
Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis (2010) 2.45
Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol (2002) 2.36
Papillary tumor of the pineal region. Am J Surg Pathol (2003) 2.13
Henipavirus and Tioman virus antibodies in pteropodid bats, Madagascar. Emerg Infect Dis (2007) 2.05
Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J Immunol (2004) 1.96
Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. J Virol (2002) 1.69
West Nile virus epidemic in horses, Tuscany region, Italy. Emerg Infect Dis (2002) 1.60
Evidence of recombination and genetic diversity in human rhinoviruses in children with acute respiratory infection. PLoS One (2009) 1.58
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53
Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation. Nat Immunol (2002) 1.51
Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. Am J Hum Genet (2009) 1.49
Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol (2009) 1.45
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43
Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model. Virology (2009) 1.40
An innovative tool for moving malaria PCR detection of parasite reservoir into the field. Malar J (2013) 1.40
Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis (2011) 1.38
Specific detection of Nipah virus using real-time RT-PCR (TaqMan). J Virol Methods (2004) 1.34
Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase. Vaccine (2009) 1.32
Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol (2004) 1.29
Human macrophages, but not dendritic cells, are activated and produce alpha/beta interferons in response to Mopeia virus infection. J Virol (2004) 1.27
A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype. J Clin Microbiol (2011) 1.27
Reemergence of Chikungunya virus in Cambodia. Emerg Infect Dis (2012) 1.24
Molecular monitoring of causative viruses in child acute respiratory infection in endemo-epidemic situations in Shanghai. J Clin Virol (2010) 1.22
Preventive transfusion in Dengue shock syndrome-is it necessary? J Pediatr (2003) 1.20
Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe. Vet Res (2013) 1.20
Establishment of a Nipah virus rescue system. Proc Natl Acad Sci U S A (2006) 1.20
Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect (2006) 1.20
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology (2003) 1.19
Risk factors for hemorrhage in severe dengue infections. J Pediatr (2002) 1.18
Simultaneous detection of respiratory viruses in children with acute respiratory infection using two different multiplex reverse transcription-PCR assays. J Virol Methods (2009) 1.16
A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses. J Virol (2012) 1.15
Current Assessment of Yellow Fever and Yellow Fever Vaccine. Curr Infect Dis Rep (2004) 1.14
Dynamic of H5N1 virus in Cambodia and emergence of a novel endemic sub-clade. Infect Genet Evol (2012) 1.13
Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol (2008) 1.12
High genetic diversity of measles virus, World Health Organization European Region, 2005-2006. Emerg Infect Dis (2008) 1.11
Correlation between bocavirus infection and humoral response, and co-infection with other respiratory viruses in children with acute respiratory infection. J Clin Virol (2010) 1.09
Benefit of sustained virological response to combination therapy on graft survival of liver transplanted patients with recurrent chronic hepatitis C. Am J Transplant (2005) 1.08
Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci U S A (2006) 1.07
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins. Virology (2006) 1.06
Nipah virus uses leukocytes for efficient dissemination within a host. J Virol (2011) 1.05
Detection of Japanese encephalitis virus antibodies in bats in Southern China. Am J Trop Med Hyg (2008) 1.04
Cocirculation of measles virus genotype B2 and B3.1 in Central African Republic during the 2000 measles epidemic. J Med Virol (2006) 1.03
Human dendritic cells infected with the nonpathogenic Mopeia virus induce stronger T-cell responses than those infected with Lassa virus. J Virol (2011) 1.02
Experimental infection of squirrel monkeys with nipah virus. Emerg Infect Dis (2010) 1.02
Adaptation of wild-type measles virus to tissue culture. J Virol (2002) 1.02
Phylogenetic relationships of West Nile viruses isolated from birds and horses in Israel from 1997 to 2001. Virus Genes (2003) 1.01
Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. Histochem Cell Biol (2012) 1.00
Natural simian foamy virus infection in wild-caught gorillas, mandrills and drills from Cameroon and Gabon. J Gen Virol (2004) 1.00
Detection and molecular characterization of foamy viruses in Central African chimpanzees of the Pan troglodytes troglodytes and Pan troglodytes vellerosus subspecies. J Med Primatol (2006) 0.99
Use of a multiplex PCR/RT-PCR approach to assess the viral causes of influenza-like illnesses in Cambodia during three consecutive dry seasons. J Med Virol (2010) 0.98
Characterization of Lassa virus cell entry and neutralization with Lassa virus pseudoparticles. J Virol (2009) 0.97
Interferons mediate terminal differentiation of human cortical thymic epithelial cells. J Virol (2002) 0.96
Rapid failure of pig islet transplantation in non human primates. Xenotransplantation (2002) 0.95
Superior neutralizing antibody response and protection in mice vaccinated with heterologous DNA prime and virus like particle boost against HPAI H5N1 virus. PLoS One (2011) 0.92
The nonstructural proteins of Nipah virus play a key role in pathogenicity in experimentally infected animals. PLoS One (2010) 0.92
Genetic variability of human metapneumovirus amongst an all ages population in Cambodia between 2007 and 2009. Infect Genet Evol (2011) 0.92
High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. J Virol (2006) 0.91
Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever. Clin Vaccine Immunol (2007) 0.91
Crimean-Congo haemorrhagic fever cases in Turkey. Scand J Infect Dis (2007) 0.91
Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus. PLoS One (2011) 0.90
Biochemical and kinetic analysis of the influenza virus RNA polymerase purified from insect cells. Biochem Biophys Res Commun (2009) 0.89
Dengue virus M protein contains a proapoptotic sequence referred to as ApoptoM. J Gen Virol (2003) 0.89
DNA prime and virus-like particle boost from a single H5N1 strain elicits broadly neutralizing antibody responses against head region of H5 hemagglutinin. J Infect Dis (2013) 0.89
Gene expression profiling and subgroup identification of oligodendrogliomas. Oncogene (2004) 0.89
Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus. Biochem Biophys Res Commun (2005) 0.89
design of multiplexed detection assays for identification of avian influenza a virus subtypes pathogenic to humans by SmartCycler real-time reverse transcription-PCR. J Clin Microbiol (2008) 0.88
Complex dynamic of dengue virus serotypes 2 and 3 in Cambodia following series of climate disasters. Infect Genet Evol (2012) 0.88
Proliferative activity and nestin expression in periventricular cells of the adult rat brain. Neuroreport (2003) 0.88
Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Acta Neurochir (Wien) (2009) 0.88
Cell surface delivery of the measles virus nucleoprotein: a viral strategy to induce immunosuppression. J Virol (2004) 0.88
Low-density macroarray for rapid detection and identification of Crimean-Congo hemorrhagic fever virus. J Clin Microbiol (2009) 0.87
Dengue v2V--new global initiative supporting transition from vaccine to vaccination. Vaccine (2009) 0.87
Subcellular localization of 14-3-3 proteins in Toxoplasma gondii tachyzoites and evidence for a lipid raft-associated form. FEMS Microbiol Lett (2003) 0.87
Interplay between virus-specific effector response and Foxp3 regulatory T cells in measles virus immunopathogenesis. PLoS One (2009) 0.87
The Israeli strain IS-98-ST1 of West Nile virus as viral model for West Nile encephalitis in the Old World. Virol J (2004) 0.87
Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Microbes Infect (2006) 0.87